๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The treatment of rheumatoid arthritis and necrotizing vasculitis with penicillamine

โœ Scribed by Dr. Israeli A. Jaffe


Publisher
John Wiley and Sons
Year
1970
Tongue
English
Weight
922 KB
Volume
13
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


D-penicillamine in the treatment of rheu
โœ Ian K. Tsang; Caroline A. Patterson; Howard B. Stein; Harold S. Robinson; Denys ๐Ÿ“‚ Article ๐Ÿ“… 1977 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 338 KB ๐Ÿ‘ 3 views
The mortality of rheumatoid vasculitis c
โœ Alexandre E. Voskuyl; Aeilko H. Zwinderman; Marie Louise Westedt; Jan P. Vandenb ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 532 KB

To determine whether the mortality of patients with rheumatoid vasculitis (RV) is increased in comparison with that of patients with rheumatoid arthritis (RA). Methods. The mortality of all RV patients identified in 1980-1992 (n = 61) was compared with that of 244 RA controls matched for the year t

The relationship of sulfoxidation status
โœ R. Madhok; A. Zoma; H. I. Torley; H. A. Capell; R. Waring; J. A. Hunter ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 328 KB ๐Ÿ‘ 2 views

Penicillamine shows some structural similarities to carbocysteine. The ability to oxidize carbocysteine, i.e., the sulfoxidation status, shows a bimodal distribution in the general population. In this study, sulfoxidation status was determined in 50 of 60 rheumatoid arthritis patients receiving peni

Pharmacokinetics of reduced d-penicillam
โœ Michael Butler; George Carruthers; Manfred Harth; David Freeman; John Percy; Dal ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 503 KB

Penicillamine (pp dimethylcysteine, 3 mercaptovaline) is a trifunctional amino acid with carboxyl, amino, and sufhydryl groups. The D-isomer is a remittive agent of similar efficacy to gold in the treatment of persistent rheumatoid arthritis (I). Despite the widespread use of the drug, little infor